Assess Fibrin in Brains With AD/ADRD

Clinical trial NCT05336695 · RECRUITING

Trial details

NCT number: NCT05336695
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Dementia of Alzheimer Type

Start date: 2022-03-29
Primary completion: 2026-09-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.